查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1726402

全球预测疾病分析市场：市场规模、份额、趋势分析（按组件、部署方法、最终用途和地区）、细分市场预测（2025-2030 年）

Predictive Disease Analytics Market Size, Share & Trends Analysis Report By Component (Hardware, Software & Services), By Deployment (On-premise, Cloud-based), By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10个工作天内

价格

预测疾病分析市场的成长与趋势：

根据 Grand View Research, Inc. 的新报告，全球预测疾病分析市场规模预计到 2030 年将达到 102 亿美元，2025 年至 2030 年的复合年增长率为 22.7%。

预测疾病分析是指医疗保健组织、医院和医生用来分析和处理患者数据以提供数据主导的优质护理、准确诊断和个人化治疗的软体解决方案。预测分析是一种改善医疗保健患者治疗结果的先进技术。

此外，医疗保健提供者使用预测分析解决方案来了解疾病传播、疾病管理、风险管理和轨迹，并为患者提供适当的护理以获得最佳结果。医疗保健提供者使用它来评估个人健康的风险率以及预测和准备未来的结果。各个层面的使用以避免不必要的开支也增加了这项技术的使用，预计这种使用将在整个预测期内持续下去。因此，全球预测疾病分析市场预计将成长。

预测分析在应对 COVID-19 挑战、减少不良患者治疗结果的发生率以及解决危机期间的资源管理方面发挥关键作用。疫情期间产生的大量患者数据不仅为分析公司和医疗保健部门提供了正确分析疾病传播的数据，还有助于资源配置。包括医院在内的多家发展机构正在使用预测分析来确定患者出现严重症状、感染疾病/疾病轨迹和其他几个参数的机率。例如，2020 年，美国克利夫兰诊所的研究人员创建了一个自动分析模型来预测个人检测呈阳性的可能性。因此，它正在推动市场成长。

由于慢性病负担不断加重、个人化和实证医学的出现、医疗保健领域对效率的需求不断增长，以及透过消除不必要成本来降低医疗保健支出的需求不断增长，全球市场正在迅速扩张。根据疾病管制中心的数据，每 10 个美国人中就有 6 个患有至少一种慢性疾病，例如心臟病、中风、癌症或糖尿病。因此，产品需求的增加进一步促进了市场成长。

推动市场成长的另一个重要原因是使用实证医学为正确的患者提供正确的治疗。近年来，电子健康记录(EHR) 在病患记录中的使用增加，在美国，执业医师对 EHR 的采用率从 2008 年的 42% 增加到 2021 年的近 88%。预测性医疗分析利用 EHR 推荐最佳治疗方案和药物。这不仅显着降低了患者的医疗费用，而且还改善了治疗效果。电子医疗系统、分析工具和人工智慧（AI）的采用有望推动市场发展。由于全球慢性病负担不断加重，医疗费用逐年上涨。

预测疾病分析市场中的公司正在不断扩大其产品和服务组合併加速其发展。例如，2022 年 6 月，健康顾问公司 Engagys LLC 宣布推出一项针对医疗系统、健康计画和医疗技术领导者的全新经济实惠的订阅服务。我们的执行咨询服务旨在为医疗保健客户参与负责人提供实用、可操作的指导、见解和最佳实践。预计这将加强公司在预测分析解决方案中的地位并进一步促进市场成长。

预测疾病分析市场：分析概述

  • 预计预测期内云端基础的解决方案将以最高的复合年增长率成长。易于储存、廉价的资本要求、更高的灵活性和效率是其发展的驱动力。
  • 根据最终用途，医疗保健支付方部门在 2023 年占据了市场主导地位。保险公司、健康计画发起人和其他第三方支付方等支付方是医疗保健环境中预测分析的主要受益者之一。从而促进该领域的成长。
  • 在北美，由于慢性病盛行率上升、预防保健意识增强以及老年人口比例增加，预计该地区将占据最大的市场占有率。

目录

第一章 分析方法与范围

第二章执行摘要

3. 预测疾病分析市场：驱动因素、趋势与范围

  • 市场联动展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制分析
  • 预测疾病分析市场：分析工具
    • 产业分析：波特五力分析
    • PESTEL分析
    • 法律规范
    • 新兴科技趋势
    • 案例研究和见解
    • COVID-19影响分析

第四章预测疾病分析市场：各组成部分的估计和趋势分析

  • 细分仪表板
  • 全球预测疾病分析各组成部分的变异分析
  • 全球预测疾病分析市场规模及趋势分析（2018-2030）
  • 软体和服务市场
  • 五金市场

第五章预测疾病分析市场：按部署方法的估计和趋势分析

  • 细分仪表板
  • 全球预测疾病分析市场趋势分析（按部署法）
  • 全球预测疾病分析市场规模和趋势分析（按部署类型）（2018-2030 年）
  • 本地市场
  • 云端基础的市场

6. 预测疾病分析市场：依最终用途的估计和趋势分析

  • 细分仪表板
  • 全球预测疾病分析变异分析（依最终用途）
  • 全球预测疾病分析市场规模和趋势分析（按最终用途）（2018-2030 年）
  • 医疗保健付款人
  • 医疗保健提供者
  • 其他最终用户

第七章预测疾病分析市场：按地区估计和趋势分析

  • 各地区市场占有率分析（2024 年及 2030 年）
  • 市场仪表板：按地区
  • 市场规模预测及趋势分析（2018-2030年）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争态势

  • 公司/竞争对手分类
  • 企业市场分析（2024年）
  • 公司简介/上市公司
    • Oracle
    • Cerner Corporation
    • IBM
    • SAS
    • Allscripts Healthcare Solutions Inc.
    • MedeAnalytics, Inc.
    • Health Catalyst
    • Apixio Inc
    • GE Healthcare（a division of General Electric Company）
    • Siemens Healthineers
Product Code: GVR-4-68040-043-8

Predictive Disease Analytics Market Growth & Trends:

The global predictive disease analytics market size is expected to reach USD 10.2 billion by 2030 and is expected to expand at 22.7% CAGR from 2025 to 2030, according to a new report by Grand View Research, Inc. Predictive disease analytics refers to software solutions used by healthcare organizations, hospitals, and physicians to analyze and process patient data in order to provide data-driven, high-quality care, precise diagnostics, and individualized treatments. Predictive analytics is an advanced method to enhance patient outcomes in healthcare.

Additionally, predictive analytics solutions are used by healthcare providers to comprehend disease prevalence, disease management, risk management & trajectories, and to provide suitable medical care to patients for optimal outcomes. Healthcare providers use it to evaluate the risk rate to an individual's health as well as predict future outcomes in preparation. Its use at various levels to avoid unnecessary expenditure had also increased the utilization of this technology, which is anticipated to continue throughout the forecast period. As a result, the global predictive disease analytics market is expected to grow.

Predictive analytics has played a significant part in combating COVID-19 problems, decreasing the incidence of poor outcomes for patients, and addressing resource management during the crisis. The massive amount of patient data produced during the outbreak not only provided analytics firms and the healthcare sector with data to properly analyze disease spread, but it also aided in resource allocation. Several institutions, including hospitals, was using predictive analytics to determine the probability of a patient developing severe symptoms, the trajectory of their infection/disease, and several other parameters. For instance, in 2020, researchers at the Cleveland Clinic in the U. S. created an automated analytics model that predicted an individual's chance of testing positive. Hence, propelling the market growth.

The global market is expanding rapidly as a result of the increasing burden of chronic diseases, the emergence of personalized and evidence-based medicine, the growing need for increased efficiency in the healthcare sector, and the growing demand to reduce healthcare costs by eliminating unnecessary costs. As per the center for disease control, six out of every ten Americans have at least one chronic illness, such as heart disease or stroke, cancer, or diabetes. Hence, it will increase the product demand and further boost the market growth.

Another important reason driving market growth is the use of evidence-based medicine to provide the right kind of treatment to the right patient. The utilization of Electronic Health Records (EHRs) for patient records has increased in recent years, with adoption of EHRs in the case of office-based doctors increasing from 42% in 2008 to nearly 88% in 2021 in the U. S. Healthcare predictive analytics makes use of EHRs to recommend the best course of action in the event of a medical treatment or medication. This not only greatly reduces patient costs but also leads to improved outcomes. The adoption of electronic health systems, analytics tools, and artificial intelligence (AI) are expected to drive market development. The expense of healthcare has risen over the years owing to the increasing burden of chronic diseases on a global level.

The companies in the predictive disease analytics market are continuously expanding their product and services portfolio to accelerate the development of the product. For instance, in June 2022, Engagys LLC, a Health Consultant Company, announced the debut of a new affordable subscription service for healthcare systems, health plans, & healthcare technology leaders. Executive Advisory Services is intended to provide healthcare customer engagement practitioners with practical and actionable guidance, insights, and best practices that they can put to use immediately. This is expected to strengthen the company's position in predictive analytics solution and further boost the market growth.

Predictive Disease Analytics Market Report Highlights:

  • Cloud-based solutions are anticipated to have the highest CAGR during the forecast period. The ease of storage, inexpensive capital requirements, increased flexibility, and efficiency are attributed to its development.
  • On the basis of end user, payer segment dominated the market in 2023.Payers, such as insurance firms, health plan sponsors, as well as other third-party payers, are among the primary beneficiaries of predictive analytics in healthcare settings. Thus, boosting the segment growth.
  • Due to the rising prevalence of chronic diseases, greater awareness of preventive health and rising percentage of geriatric population in North America, the region had the largest market share.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Component Type Segment
    • 1.2.2. Deployment Segment
    • 1.2.3. End User Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. Predictive Disease Analytics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rise in government initiatives and an increasing amount of money being invested in the healthcare industry
      • 3.2.1.2. Technological advancements in AI and machine learning
      • 3.2.1.3. Increasing prevalence of chronic diseases
      • 3.2.1.4. Growing shift towards personalized medicine
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Growing data privacy concerns
      • 3.2.2.2. Lack of skilled professionals
      • 3.2.2.3. High implementation cost
  • 3.3. Predictive disease analytics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political Landscape
      • 3.3.2.2. Technological Landscape
      • 3.3.2.3. Economic Landscape
      • 3.3.2.4. Environmental Landscape
      • 3.3.2.5. Legal Landscape
      • 3.3.2.6. Social Landscape
    • 3.3.3. Regulatory Framework
    • 3.3.4. Emerging Technologies Trends
    • 3.3.5. Case Study & Insights
      • 3.3.5.1. Use Cases
    • 3.3.6. COVID-19 Impact Analysis

Chapter 4. Predictive Disease Analytics Market: Component Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Predictive Disease Analytics Movement Analysis
  • 4.3. Global Predictive Disease Analytics Market Size & Trend Analysis, by Component, 2018 - 2030 (USD Million)
  • 4.4. Software and Services Market
    • 4.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.5. Hardware Market
    • 4.5.1. Market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 5. Predictive Disease Analytics Market: Deployment Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Predictive Disease Analytics Movement Analysis
  • 5.3. Global Predictive Disease Analytics Market Size & Trend Analysis, by Component, 2018 - 2030 (USD Million)
  • 5.4. On-premise Market
    • 5.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)
  • 5.5. Cloud-based Market
    • 5.5.1. Market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 6. Predictive Disease Analytics Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Predictive Disease Analytics Market End Use Movement Analysis
  • 6.3. Global Predictive Disease Analytics Market Size & Trend Analysis, by End Use, 2018 - 2030 (USD Million)
  • 6.4. Healthcare Payers
    • 6.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.5. Healthcare Providers
    • 6.5.1. Market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.6. Other End Users
    • 6.6.1. Market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 7. Predictive Disease Analytics Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size & Forecasts Trend Analysis, 2018 - 2030:
  • 7.4. North America
    • 7.4.1. U.S.
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. U.S. market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.4.2. Canada
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Canada market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.4.3. Mexico
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. Mexico market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. UK
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. UK market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.2. Germany
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Germany market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.3. France
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. France market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.4. Italy
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Italy market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.5. Spain
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. Spain market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.6. Norway
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Norway market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.7. Sweden
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Regulatory framework
      • 7.5.7.3. Competitive scenario
      • 7.5.7.4. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.8. Denmark
      • 7.5.8.1. Key country dynamics
      • 7.5.8.2. Regulatory framework
      • 7.5.8.3. Competitive scenario
      • 7.5.8.4. Denmark market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Japan
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Japan market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.6.2. China
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. China market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.6.3. India
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. India market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.6.4. Australia
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Australia market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.6.6. Thailand
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Thailand market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Brazil
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. Brazil market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.7.2. Argentina
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Argentina market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. South Africa
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework
      • 7.8.1.3. Competitive scenario
      • 7.8.1.4. South Africa market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.8.2. Saudi Arabia
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.8.3. UAE
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Regulatory framework
      • 7.8.3.3. Competitive scenario
      • 7.8.3.4. UAE market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.8.4. Kuwait
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Regulatory framework
      • 7.8.4.3. Competitive scenario
      • 7.8.4.4. Kuwait market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Company Market Position Analysis, 2024
  • 8.3. Company Profiles/Listing
    • 8.3.1. Oracle
      • 8.3.1.1. Company overview
      • 8.3.1.2. Financial performance
      • 8.3.1.3. Product benchmarking
      • 8.3.1.4. Strategic initiatives
    • 8.3.2. Cerner Corporation
      • 8.3.2.1. Company overview
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Product benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. IBM
      • 8.3.3.1. Company overview
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Product benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. SAS
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Allscripts Healthcare Solutions Inc.
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. MedeAnalytics, Inc.
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Health Catalyst
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Apixio Inc
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. GE Healthcare (a division of General Electric Company)
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Siemens Healthineers
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America Predictive disease analytics market, by country, 2018 - 2030 (USD Million)
  • Table 3 North America Predictive disease analytics market, by component, 2018 - 2030 (USD Million)
  • Table 4 North America Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
  • Table 5 North America Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
  • Table 6 U.S. Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
  • Table 7 U.S. Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
  • Table 8 U.S. Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
  • Table 9 Canada Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
  • Table 10 Canada Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
  • Table 11 Canada Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
  • Table 12 Mexico Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
  • Table 13 Mexico Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
  • Table 14 Mexico Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
  • Table 15 Europe Predictive disease analytics market, by country, 2018 - 2030 (USD Million)
  • Table 16 Europe Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
  • Table 17 Europe Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
  • Table 18 Europe Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
  • Table 19 UK Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
  • Table 20 UK Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
  • Table 21 UK Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
  • Table 22 Germany Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
  • Table 23 Germany Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
  • Table 24 Germany Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
  • Table 25 France Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
  • Table 26 France Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
  • Table 27 France Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Italy Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
  • Table 29 Italy Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
  • Table 30 Italy Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
  • Table 31 Spain Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
  • Table 32 Spain Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
  • Table 33 Spain Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
  • Table 34 Denmark Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
  • Table 35 Denmark Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
  • Table 36 Denmark Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
  • Table 37 Sweden Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
  • Table 38 Sweden Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
  • Table 39 Sweden Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
  • Table 40 Norway Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
  • Table 41 Norway Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
  • Table 42 Norway Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific Predictive disease analytics market, by country, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
  • Table 47 China Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
  • Table 48 China Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
  • Table 49 China Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
  • Table 50 Japan Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
  • Table 51 Japan Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
  • Table 52 Japan Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
  • Table 53 India Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
  • Table 54 India Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
  • Table 55 India Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
  • Table 56 South Korea Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
  • Table 57 South Korea Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
  • Table 58 South Korea Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
  • Table 59 Australia Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
  • Table 60 Australia Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
  • Table 61 Australia Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
  • Table 62 Thailand Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
  • Table 63 Thailand Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
  • Table 64 Thailand Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
  • Table 65 Latin America Predictive disease analytics market, by country, 2018 - 2030 (USD Million)
  • Table 66 Latin America Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
  • Table 67 Latin America Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
  • Table 68 Latin America Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Brazil Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
  • Table 70 Brazil Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
  • Table 71 Brazil Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
  • Table 72 Argentina Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
  • Table 73 Argentina Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
  • Table 74 Argentina Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
  • Table 75 MEA Predictive disease analytics market, by country, 2018 - 2030 (USD Million)
  • Table 76 MEA Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
  • Table 77 MEA Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
  • Table 78 MEA Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
  • Table 79 South Africa Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
  • Table 80 South Africa Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
  • Table 81 South Africa Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
  • Table 85 UAE Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
  • Table 86 UAE Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
  • Table 87 UAE Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
  • Table 88 Kuwait Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
  • Table 89 Kuwait Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
  • Table 90 Kuwait Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 Predictive disease analytics market: Market outlook
  • Fig. 5 Predictive disease analytics market: Segment outlook
  • Fig. 6 Predictive disease analytics market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 Predictive disease analytics market driver impact
  • Fig. 9 Predictive disease analytics market restraint impact
  • Fig. 10 Predictive disease analytics market: Component outlook and key takeaways
  • Fig. 11 Predictive disease analytics market: Component movement analysis
  • Fig. 12 Software & Services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 13 Hardware market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 14 Predictive disease analytics market: Deployment Mode outlook and key takeaways
  • Fig. 15 Predictive disease analytics market: Deployment Mode movement analysis
  • Fig. 16 On-premise market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 17 Cloud-based market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 18 Predictive disease analytics market: End User outlook and key takeaways
  • Fig. 19 Predictive disease analytics market: End User movement analysis
  • Fig. 20 Healthcare Payers Market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 21 Healthcare Providers Market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 22 Other End Users market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 23 Global Predictive disease analytics market: Regional outlook and key takeaways
  • Fig. 24 Global Predictive disease analytics market: Regional movement analysis
  • Fig. 25 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Key country dynamics
  • Fig. 27 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Key country dynamics
  • Fig. 29 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Key country dynamics
  • Fig. 31 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Key country dynamics
  • Fig. 34 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Key country dynamics
  • Fig. 36 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Key country dynamics
  • Fig. 38 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Key country dynamics
  • Fig. 40 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Key country dynamics
  • Fig. 42 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Key country dynamics
  • Fig. 44 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Key country dynamics
  • Fig. 46 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Key country dynamics
  • Fig. 48 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Key country dynamics
  • Fig. 51 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Key country dynamics
  • Fig. 53 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)